Idarubicin at Different Dosages as Induction Therapy for Newly Diagnosed Acute Myeloid Leukaemia
Clinical trial NCT02277847 · UNKNOWN
Trial details
- NCT number
- NCT02277847
- Sponsor
- Guangdong Provincial People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2017-06-01
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.